GlassScriptPhysician profile
Robert Kevin Lynch
NPI 1417953589
$10,728.82
in general payments reported to CMS, 2019-2025
19 companies · $5,542 in 2025
The $5,542 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,794 · 2020: $343 · 2021: $408 · 2022: $736 · 2023: $284 · 2024: $622 · 2025: $5,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $1,869 · Travel and Lodging: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $1,869.05 |
| Travel and Lodging | $578.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,569.37 | 2019-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,416.34 | 2019 | |
| Ethicon US, LLC | $2,078.04 | 2019-2025 | Stratafix, Vistaseal, Harmonic |
| Davol INC. | $150.49 | 2025 | Phasix Mesh |
| Kowa Pharmaceuticals America, INC. | $101.25 | 2022-2023 | Seglentis, Livalo |
| Conmed Corporation | $66.84 | 2020-2021 | |
| Zyla Life Sciences, INC. | $56.45 | 2020 | |
| Tactile Systems Technology INC | $49.20 | 2019-2020 | |
| Acell, INC. | $34.61 | 2019-2020 | |
| Smith+Nephew, INC. | $34.12 | 2020-2021 | |
| Allergan, INC. | $30.50 | 2022 | |
| Abbvie INC. | $26.66 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $22.17 | 2025 | Exparel |
| Medtronic, INC. | $20.42 | 2025 | Venaseal |
| Janssen Pharmaceuticals, INC | $18.11 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $15.91 | 2021 | |
| Novo Nordisk INC | $15.36 | 2025 | Wegovy |
| Assertio Therapeutics, INC. | $11.49 | 2020 | |
| Integra Lifesciences Corporation | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.